182 related articles for article (PubMed ID: 3486060)
1. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
2. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
5. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
Clement LT; Tedder TF; Gartland GL
J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
[TBL] [Abstract][Full Text] [Related]
6. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
8. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
9. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
Momburg F; Koretz K; Von Herbay A; Möller P
Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
[TBL] [Abstract][Full Text] [Related]
10. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells.
Fermand JP; Schmitt C; Brouet JC
Eur J Immunol; 1985 Dec; 15(12):1183-7. PubMed ID: 3878788
[TBL] [Abstract][Full Text] [Related]
11. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
Wilson KM; Labeta MO; Pawelec G; Fernandez N
Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
[TBL] [Abstract][Full Text] [Related]
12. Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
Delia D; Cattoretti G; Bonati A; Villa S; De Braud F; Buscaglia M
Clin Exp Immunol; 1985 Feb; 59(2):305-14. PubMed ID: 2579752
[TBL] [Abstract][Full Text] [Related]
13. HLA-DP can be expressed with or without -DR molecules on a malignant B cell line.
Pesando JM; Graf L; Hoffman P
J Immunol; 1986 Sep; 137(6):1932-6. PubMed ID: 3489045
[TBL] [Abstract][Full Text] [Related]
14. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
[TBL] [Abstract][Full Text] [Related]
16. MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.
Guy K; Middleton PG; Docherty LJ; De Angelis CL; Steel CM
Immunology; 1986 Dec; 59(4):603-10. PubMed ID: 3026962
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
18. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
19. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]